Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial
- Submitting institution
-
University of Plymouth
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 2076
- Type
- D - Journal article
- DOI
-
10.1002/hep.29852
- Title of journal
- Hepatology
- Article number
- -
- First page
- 2113
- Volume
- 67
- Issue
- 6
- ISSN
- 0270-9139
- Open access status
- Not compliant
- Month of publication
- -
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
20
- Research group(s)
-
-
- Citation count
- 12
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Matthew Cramp made a substantial contribution to the conduct of the study and recruited a large number of the subjects. AND Matthew Cramp made a significant contribution to the writing of the manuscript.
- Non-English
- No
- English abstract
- -